Iron deficiency affects 500 million people, yet the molecular role of iron in gene expression remains poorly characterized. In addition, the alterations in global gene expression after iron chelation remain unclear and are important to assess for understanding the molecular pathology of iron deficiency and the biological effects of chelators. Considering this, we assessed the effect on whole genome gene expression of two iron chelators (desferrioxamine and 2-hydroxy-1-napthylaldehyde isonicotinoyl hydrazone) that have markedly different permeability properties. Sixteen genes were significantly regulated by both ligands, whereas a further 50 genes were significantly regulated by either compound. Apart from ironmediated regulation of expression via hypoxia inducible factor-1␣, it was noteworthy that the transcription factor p53 was also involved in iron-regulated gene expression. Examining 16 genes regulated by both chelators in normal and neoplastic cells, five genes (APP, GDF15, CITED2, EGR1, and PNRC1) were significantly differentially expressed between the cell types. In view of their functions in tumor suppression, proliferation, and apoptosis, these findings are important for understanding the selective antiproliferative effects of chelators against neoplastic cells. Most of the genes identified have not been described previously to be iron-regulated and are important for understanding the molecular and cellular effects of iron depletion.
Iron deficiency affects approximately 500 million people. However, despite the enormity of this problem, very little is understood concerning the precise molecular roles played by iron in growth, cell-cycle progression, and apoptosis.
Iron plays essential roles in cells, including DNA synthesis and cell cycle control (Buss et al., 2003) . It is well known that iron deficiency induced by chelators results in a G 1 /S arrest and apoptosis (Buss et al., 2003) . The best-characterized role of iron in proliferation involves its function in the rate-limiting step of DNA synthesis catalyzed by ribonucleotide reductase (Buss et al., 2003) . Iron has also been shown to regulate the expression of a variety of molecules involved in cell-cycle control (e.g., p21
CIP1/WAF1 , GADD45, p53, cyclin D1, etc.) (Gao and Richardson, 2001; Liang and Richardson, 2003) and metastasis suppression (e.g., N-myc downstreamregulated gene-1; NDRG-1) (Le and Richardson, 2004) . Because iron is important for mitochondrial heme and iron sulfur cluster synthesis, it is likely that iron chelation will also affect basic mitochondrial metabolism and function.
Iron chelators are well known therapeutics for the treatment of iron-overload disease and some of these agents show potential for cancer therapy (Buss et al., 2003; Whitnall et al., 2006) . In general, lipophilic chelators are more effective at inhibiting [ 3 H]thymidine incorporation, DNA synthesis, and proliferation than their hydrophilic counterparts (Rich-ardson et al., 1995) . A good example of this is provided by comparing the activity of the tridentate lipophilic ligand 2-hydroxy-1-napthylaldehyde isonicotinoyl hydrazone (311; Fig. 1A ) and the hexadentate hydrophilic compound desferrioxamine (DFO; Fig. 1A ). Both are high-affinity iron(III) chelators (Richardson and Bernhardt, 1999 ) that demonstrate distinct differences in activity (Richardson et al., 1994 (Richardson et al., , 1995 Darnell and Richardson, 1999) . In fact, DFO shows limited permeability and iron chelation efficacy, which leads to low antiproliferative efficacy, whereas 311 is membranepermeable and demonstrates marked antiproliferative effects (Richardson et al., 1994 (Richardson et al., , 1995 Darnell and Richardson, 1999) .
Unlike other cytotoxic chelators, upon binding iron, DFO and 311 do not generate cytotoxic radicals, their effects being due to induction of iron depletion (Chaston et al., 2003) . In addition, DFO and 311 up-regulate the iron-regulated gene transferrin receptor 1 (TfR1) (Darnell and Richardson, 1999) .
Important regulators of intracellular iron status are the iron-regulatory proteins 1 and 2 (IRP1 and -2) that bind conserved iron-responsive elements (IREs) in the 3Ј-and 5Ј-untranslated regions (UTRs) of mRNAs that play roles in iron metabolism (Sanchez et al., 2007) . Previous studies showed that DFO and 311 deplete cellular iron and effectively increase IRP-RNA-binding activity (Darnell and Richardson, 1999) . Depending on iron status, the IRPs post-transcriptionally regulate the expression of genes, including TfR1, which is involved in iron uptake, and ferritin H-and L-chain, which play crucial roles in iron storage (Sanchez et al., 2007) . However, this is not the only mechanism controlling gene expression in response to iron; the other well known system is mediated by hypoxia-inducible factor-1␣ (HIF-1␣) (An et al., 1998; Semenza, 1999) . The expression of the transcription factor p53 can also be regulated by iron (An et al., 1998; Liang and Richardson, 2003) . It is noteworthy that HIF1-␣ is thought to stabilize p53 and lead to its up-regulation after iron depletion (An et al., 1998) .
HIF-1 is activated under hypoxia and/or iron depletion and is composed of two subunits, a constitutively expressed ␤-subunit and the ␣-subunit (Semenza, 1999) . Un- Fig. 1 . A, structures of the chelators DFO and 311. B, the effect of various concentrations of 311 (0.25-25 M) or DFO (0.1-250 M) after a 24-h incubation at 37°C on the mRNA expression of seven genes commonly up-regulated by either of these ligands (see Table 2 ) in MCF-7 breast cancer cells. C, the effect of incubation time (3-24 h at 37°C) with 311 (25 M) or DFO (250 M) on the mRNA expression of the seven genes in B in MCF-7 cells. In B and C, TfR1 expression has been assessed as a positive control for iron depletion. Results in B and C are representative photographs of gels from three separate experiments.
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der normal oxygen tension and iron levels, HIF-1␣ is regulated by prolyl hydroxylase, which allows binding to the von Hippel-Lindau protein. This protein activates ubiquitin E3 ligase, resulting in HIF-1␣ degradation via the proteasome (Semenza, 1999) . Under oxygen and/or iron depletion, prolyl hydroxylase fails to function, leading to HIF-1␣ accumulation and nuclear translocation, where it binds to HIF-1␤ to form the HIF-1 complex, which regulates genes, such as the TfR1 (Bianchi et al., 1999) , by binding to hypoxia response elements (Semenza, 1999) .
In this investigation, we examined the effect of iron chelation on global gene expression after incubation of cells with either DFO or 311. These studies were initiated to achieve a more comprehensive understanding of the cellular response to iron depletion, which remains only preliminary. We identified a range of iron-regulated genes that play roles in diverse biological processes, including tumor suppression, proliferation, and apoptosis. Furthermore, this work was designed to also investigate further potential reasons for the selective antiproliferative activity of iron chelators in neoplastic relative to normal cells. Five iron-regulated genes have been identified that were regulated differently in neoplastic cells than in normal cells and could play a role in the selective antitumor effects of chelators.
Materials and Methods

Chelators
311 was synthesized and characterized as reported (Richardson and Bernhardt, 1999) . DFO was from Novartis (Basel, Switzerland).
Cell Culture
Human MCF-7 breast cancer cells, MRC-5 fibroblasts, SK-Mel-28 melanoma cells, DMS53 lung carcinoma cells, and SK-N-MC neuroepithelioma cells were from the American Type Culture Collection (Manassas, VA) and cultured as described previously (Le and Richardson, 2004) . Human fibroblasts were from Corielle (Camden, NJ) and grown under the same conditions as the cells above. Primary cultures of human umbilical vein endothelial cells (HUVECs) were a gift from Mr. Pat Pisansarakit (Heart Research Institute, Sydney, Australia). The MCF-7 and MRC-5 cells were used in initial experiments as their response to iron chelation by DFO and 311 have been well studied (Yuan et al., 2004) . Murine embryonic fibroblasts (MEFs) from control and homozygous HIF-1␣ knockout mice were obtained from Dr. R. Johnson (University of California, San Diego). H1299 cells (p53-null) stably transfected with tetracycline (Tet)-regulated p53 (Stein et al., 2004) were obtained from GenHunter (Nashville, TN).
Microarray Processing
The MCF-7 cells were incubated with either control medium (CON; minimum essential medium containing 10% fetal calf serum) or control medium containing DFO (250 M) or 311 (25 M) for 24 h at 37°C. These concentrations and this incubation period were used because we demonstrated that under these conditions, the chelators up-regulate iron-responsive genes (e.g., TfR1) (Darnell and Richardson, 1999) . Moreover, the higher concentration of DFO was implemented because of its limited ability to permeate membranes (Richardson et al., 1994; Darnell and Richardson, 1999) . Total RNA was isolated from cells in 1 ml of TRIzol reagent (Invitrogen, Sydney, Australia). First-strand cDNA synthesis was performed using 15 g of RNA by the Affymetrix One Cycle cDNA synthesis kit, and the cDNA products were purified via the Affymetrix GeneChip sample clean-up kit (Affymetrix, Santa Clara, CA). Using the Affymetrix in vitro transcription labeling kit, biotin-labeled cRNA was prepared from the cDNA.
After purification with the above-mentioned clean-up kit, the quantity of the products was ascertained using the Nanochip protocol on a Bioanalyser 2100 (Agilent Technologies, Santa Clara, CA). Labeled cRNA (20 g) was fragmented to 50 to 200 base pairs, and then its quality was checked again. Samples (cRNA, 0.05 g/l) that passed this checkpoint were then prepared for hybridization to the Human Genome U133 Plus 430 2.0 array. This consists of Ͼ47,000 transcripts from over 38,500 genes. On completion of hybridization and washing, microarray chips were scanned with the Affymetrix GeneChip Scanner 3000 (Affymetrix).
Microarray Data Analysis
Gene Expression Analysis. A two phase strategy was used to identify differentially expressed genes. First, genome-wide screening was performed using Affymetrix GeneChips. The empirical Bayes procedure (Suryo Rahmanto et al., 2007) was applied to detect genes most likely to be differentially expressed between control and chelator-treated samples. Individual p values were then adjusted using the Holm step-down procedure to reduce false positives (Suryo Rahmanto et al., 2007) . Statistical analyses of data from Affymetrix Genechips were used to produce a list of genes with p Ͻ 0.05. This analysis was not meant to provide proof of differential expression. Rather, definitive evidence of differential expression was obtained from RT-PCR assessment of samples used for the microarray and at least three other independent samples.
Annotation. Functional annotation of genes was assigned through Gene Ontology (http://www.geneontology.org) and classifications obtained through the public databases NetAffx (http://www.affymetrix. com/analysis/index.affx) and DAVID (http://david.abcc.ncifcrf.gov) (Suryo Rahmanto et al., 2007) .
Data Availability. The complete data set can be accessed on the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/) using accession numbers GSM444834, GSM444835, and GSM444836.
RNA Isolation, RT-PCR, and Western Analysis
Total RNA was isolated using TRIzol (Invitrogen) (Suryo Rahmanto et al., 2007) . Semiquantitative RT-PCR was performed using the SuperScript III RT/Platinum Taq Mix (Suryo Rahmanto et al., 2007) . RT-PCR was shown to be semiquantitative by an optimization protocol that demonstrated it was in the log-phase of amplification. The sequences of the primers implemented are listed in Table 1 . The housekeeping gene, ␤-actin, was coamplified as an internal standard. Semiquantitative RT-PCR was used as it provides a sensitive, reproducible, and rapid estimation of gene expression and was more economical than quantitative real-time PCR. Protein isolation and Western analysis were performed using established techniques (Gao and Richardson, 2001 ).
Statistical Analysis
Results are expressed as mean Ϯ S.D. All experiments were performed at least three times. Excluding the statistical analyses of the microarray results, all data were compared using the Student's t test. Data were considered statistically significant when p Ͻ 0.05.
Results
Little is known concerning global changes in gene expression after iron depletion using chelators. To address this, we performed whole genome gene array using MCF-7 breast cancer cells. This was necessary as previous studies using other methods only examined preselected genes that have known roles or putative functions in iron metabolism (Muckenthaler et al., 2003) . Assessment of a whole genome array is vital for identifying genes regulated by iron and for understanding the response to iron depletion. Demonstration of Identification of Novel Iron-Regulated Molecules these alterations in expression was also essential in elucidating the effects of iron chelation on cells at the molecular level and to understand why some ligands show selective anticancer activity (Buss et al., 2003; Whitnall et al., 2006) .
In our studies, we compared DFO and 311, which show low and high membrane permeability, respectively (Richardson et al., 1994) . Furthermore, 311 shows greater antiproliferative activity than DFO and is far more effective at inducing iron mobilization from normal and neoplastic cells (Richardson et al., 1995) . Hence, it was important to compare the difference in response at the molecular level for both compounds. Whereas other chelators, such as di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT), have been designed that show far greater antiproliferative activity than DFO or 311 (Yuan et al., 2004) , they were not included because of their complex mechanism of action. Indeed, the cytotoxicity of Dp44mT involves not only iron chelation but also the generation of cytotoxic radicals from its metal complex (Yuan et al., 2004) . This would preclude interpretation of the effects caused by iron depletion alone.
Whole-Genome Gene Array Reveals Novel Genes Up-and Down-Regulated by Iron Depletion
Gene array analysis after a 24-h incubation with DFO (250 M) or 311 (25 M) demonstrated that there were 15 common genes significantly (p Ͻ 0.05) up-regulated and one common gene significantly (p Ͻ 0.05) down-regulated (Table 2 ) by both chelators. The expression of these genes was confirmed to be significantly altered by RT-PCR and the extent of the alteration is listed in Table 2 . Because the array can be considered to be only a screening technique, its analysis alone was not considered definitive proof of differential expression. Rather, as stated under Materials and Methods, evidence of significant differential expression was obtained from RT-PCR assessment of samples used for the microarray and also at least three independent samples.
Of the 15 up-regulated genes, only two were previously reported to be regulated in response to iron. These include the growth differentiation factor 15 (GDF15) gene, which plays a role in regulating the hormone of iron metabolism, hepcidin (Lakhal et al., 2009) , and the tumor growth and metastasis suppressor gene NDRG-1 (Le and . The only gene commonly down-regulated by both DFO or 311 was amyloid ␤ (A4) precursor protein (APP) gene that contains a type II IRE-motif in its 5Ј-UTR (Rogers et al., 2002) . The down-regulation of APP mRNA was also confirmed by RT-PCR, although the magnitude of the decrease was not as marked as that found in the array (Table 2) .
In general, after 24-h incubation with DFO or 311, the extent of up-or down-regulation was similar in these chelators (Table 2 ). This is explained by the fact that although there was an initial kinetic block to the entry of DFO into cells, it does gain access after longer incubations of 24 h to chelate iron (Richardson et al., 1994) . Moreover, because DFO was used at a higher concentration than 311 (250 versus 25 M) to ensure intracellular chelation (see Materials and Methods), this also probably led to a response of a similar magnitude. Apart from the 16 genes that were significantly up-or down-regulated by both DFO and 311 (Table 2) , there were another 20 and 30 genes that were significantly down-or upregulated by DFO or 311 alone, respectively (Tables 3 and 4) . Other commonly known iron-regulated genes such as TfR1 were not listed in these tables because the fold change was not sufficiently significant compared with the control. This provides an indication of the very high stringency used to process these array data. However, TfR1 was identified by the array to be up-regulated by iron depletion (the average fold change for 311 and DFO from three different array probes for each chelator were log 2 1.81 and 1.95, respectively; http://www.ncbi.nlm.nih.gov/geo/). As a positive control, in all samples, RT-PCR demonstrated that TfR1 mRNA was shown to be significantly up-regulated by 311 (25 M) and DFO (250 M) after a 24-h incubation at 37°C.
The complete list of genes (Tables 2-4) in which expression was significantly altered after incubation with chelators was then assessed using gene ontology software. This was done to determine whether iron depletion affected any specific biological processes in particular (Table 5 ). The classification of these processes was defined by the functional annotation of genes assigned by the Gene Ontology Consortium (Suryo Rahmanto et al., 2007) . Examining the processes associated with the differentially up-regulated genes induced by 311 and DFO demonstrated that, in general, each chelator had a similar effect (Table 5) . For both chelators, the largest proportion (28 -30%) of up-regulated genes was of "unknown function." The second largest group of up-regulated genes (16 -17%) after incubation with DFO or 311 were those affecting "nucleic acid-binding," whereas the third largest group of up-regulated genes (11%) belonged to the group of "nonreceptor Ser/Thr protein kinases" (Table 5 ). Some differences between chelators were also observed, with 6% of up-regulated genes in the 311-treated cells belonging to the group of "guanyl nucleotide exchange factor" genes, 4% being "protein kinase" genes, 3% being "select regulatory molecules," and 3% being "signaling molecule genes." None of these gene classes was identified as upregulated in DFO-treated cells. Likewise, "microtubule-binding motor binding" genes (4%), "DNA helicase" genes (3%), "exoribonuclease genes" (3%) and "receptor genes" (3%) were identified in DFO-treated cells, whereas none of these were identified to be up-regulated in cells incubated with 311 (Table 5 ).
The major group of genes down-regulated by both DFO and 311 (20 and 24%, respectively) was the "nucleic acid-binding" class ( Table 5 ). The second group of genes commonly downregulated by DFO and 311 were the "KRAB box transcription factor" series, which represented 12 and 16% of all genes, respectively. As found for the up-regulated genes, there was some discordance in gene expression between the two chelators. For instance, only in 311-treated cells was there a decrease in the expression of "G-protein modulator" genes, which represented 12% of the total (Table 5) . Given the large number of genes identified as being regulated by iron chelation, we concentrated on those commonly and significantly modified by both DFO and 311 (Table 2) .
Differential Gene Expression Depends on Chelator Concentration, and Incubation Time and Is Reversible by Adding Iron
From the 16 genes showing significantly altered expression after incubation with either DFO or 311 and then independently confirmed by RT-PCR (Table 2) , we chose seven to further investigate and characterize in detail. The seven genes assessed (i.e., BNIP3, EGR1, ERO1L, GDF15, NDRG-1, PPM1D, and PNRC1) were chosen on the basis of 1) their functional relevance to cellular proliferation, iron metabolism, and cellular survival and 2) whether antibodies were available for assessing protein levels.
A dose-and time-dependent response was observed for all seven genes, expression increasing as a function of chelator concentration (Fig. 1B) and incubation time (Fig. 1C) . For both EGR1 and NDRG-1, a slight decrease in expression relative to the control was repeatedly observed at 311 concentrations between 0.25 and 1.0 M (Fig. 1B) . Collectively, these data confirmed the results of the gene array that was done at one concentration (311, 25 M; DFO, 250 M) and time point (24 h; Table 2 ).
It was also important to assess whether the alteration in gene expression after iron depletion using DFO or 311 could be reversed by the addition of iron as ferric ammonium citrate (FAC; 100 g/ml), that donates iron to cells (Le and Richardson, 2004) . This was necessary to demonstrate that the effect observed was due to iron depletion per se and could be reversed by adding iron. For all seven genes assessed, 311 or DFO significantly (p Ͻ 0.05) increased expression, and 
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this was reversed to control levels or in some cases to significantly less (p Ͻ 0.05) than the control by a secondary incubation with FAC (Fig. 2 ). Secondary incubation with CON alone also reduced the chelator-mediated increase in expression, because the medium also contains some iron. The reversibility of gene expression mediated by adding iron demonstrated that the up-regulation was due to iron depletion and not to some other property of the chelator. However, the extent of regulation was more notable for some genes (e.g., BNIP3) than others (e.g., ERO1L). The pattern of regulation observed after iron depletion followed by iron supplementation was similar to that of the positive controls, TfR1 and NDRG-1, which are known iron-regulated genes (Le and (Fig. 2) .
Regulation of Gene Expression by the IRE-IRP Mechanism, HIF-1␣, and p53
Regulation via the IRE-IRP Mechanism. A number of mechanisms could induce alterations in gene expression after iron depletion, including the IRP-IRE interaction (Sanchez et al., 2007) . In addition, transcriptional processes mediated by HIF-1␣ and/or p53 have been shown to be regulated by iron (An et al., 1998; Liang and Richardson, 2003 ) and could also be involved. In our studies, three online software packages [m-fold (http://mfold.bioinfo. rpi.edu/cgi-bin/rna-form1.cgi), RNAfold (http://rna.tbi. univie.ac.at/cgi-bin/RNAfold.cgi), and the University of Wuerzburg Bioinformatics RNA Analyser (http://www. biozentrum.uni-wuerzburg.de/rnaanalyzer.html)] were used to assess the presence of IREs in the 3Ј-UTRs of the 15 genes identified to be significantly up-regulated after iron depletion by both chelators (Table 2) .
Stem-loop structures were identified in the 3Ј-UTR of NDRG-1 and HIG2 (Fig. 3A) . However, none of these was similar to those previously characterized within the UTRs of TfR1, ferritin etc. (Sanchez et al., 2007) . Furthermore, none of the stem-loops identified contained the conserved, canonical IRE containing the six-nucleotide loop 5Ј-CAGWGH-3Ј, where W is adenosine or uridine and H is adenosine, cytosine, or uridine (Sanchez et al., 2007) . Moreover, although the stem was thermodynamically stable in the NDRG-1 and HIG2 structures (Fig. 3A) , it was not typical of that in other IREs (e.g., see TfR1; Fig. 3A) . In fact, in the canonical IRE, the apical loop is found on a stem of five paired nucleotides containing a small asymmetrical bulge with an unpaired cytosine on the 5Ј-strand and an additional lower stem of variable length (Sanchez et al., 2007) . Hence, IREs are highly conserved structures, and the stem-loops found in NDRG-1 and HIG2 would not be conducive to IRP-binding (Sanchez et al., 2007) .
Regulation via HIF-1␣. All 16 genes regulated by both chelators (Table 2) had potential hypoxia response elements (G/C/T ACGTGC G/C) (Liu et al., 1995) within their promoters as indicated by analysis using the Genomatix program (Suite 3; Genomatix, Munich, Germany) ( Table 6 ). Furthermore, evidence from the literature suggested regulation of these genes by HIF-1␣ under a variety of conditions (Table 6 ). Considering this, the role of HIF-1␣ in the regulation of the seven genes up-regulated by iron chelation (Fig. 1, B (Fig.  3B ) similar to that found in MCF7 breast cancer cells (Fig.  2B) . In fact, these chelators significantly (p Ͻ 0.01) increased BNIP3, EGR1, and ERO1L expression in HIF-1␣(ϩ/ϩ) cells relative to cells treated control medium alone (CON), whereas no significant increase was found in HIF-1␣(Ϫ/Ϫ) cells incubated under the same conditions (Fig. 3B) . This indicated that an HIF-1␣-dependent mechanism was involved in their up-regulation after iron chelation. In terms of the effect of hypoxia (0.5% O 2 ), BNIP3 and ERO1L expression were significantly (p Ͻ 0.01) increased in HIF-1␣(ϩ/ϩ) cells only. In contrast, hypoxia significantly (p Ͻ 0.05) increased EGR1 in both HIF-1␣(ϩ/ϩ) and HIF-1␣(Ϫ/Ϫ) cells.
For NDRG-1 and PNRC1, significant up-regulation occurred after incubation with chelators or hypoxia in the presence or absence of HIF-1␣ (Fig. 3B) . This demonstrated that HIF-1␣-dependent and -independent mechanisms could be involved in regulating these genes. Chelators significantly (p Ͻ 0.05) up-regulated GDF-15 and PPM1D expression in the presence or absence of HIF-1␣, whereas hypoxia had no effect in the case of PPM1D but significantly (p Ͻ 0.05) increased GDF15 in HIF-1␣(ϩ/ϩ) cells only. (el-Deiry et al., 1992) in the promoter of the 16 genes that were regulated by both chelators (Table 2) using the Genomatix program led to their identification in the promoters of APP, EGR1, GDF15, 
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NDRG-1, and PPM1D (Table 6 ). This was supported by a literature search, which indicated that these genes can be regulated by p53 via a variety of stimuli (Table 6 ). Because p53 expression can be regulated by intracellular iron levels (An et al., 1998; Liang and Richardson, 2003) , we examined the role of p53 in the up-regulation of the seven genes examined after iron depletion (Fig. 1, B and C) . This was done by implementing H1299 cells (p53-null) transfected with wildtype p53 under the control of a Tet-responsive promoter.
Only cells containing the p53 construct incubated with Tet led to detectable p53 mRNA (Fig. 4) . The addition of Tet to H1299 transfected with the empty vector alone led to no p53 expression. It is noteworthy that incubation of H1299 cells transfected with wild-type p53 together with the chelators increased p53 expression. The mechanism involved in this effect is unclear but may involve the effect of iron depletion on stabilizing p53 mRNA leading to increased translation. The expression of GDF15, NDRG-1, and PPM1D was significantly (p Ͻ 0.05) increased in the presence of chelators in cells expressing p53, although no influence was observed in cells not expressing this transcription factor (Fig. 4) . This suggested that for these genes the increase in expression was p53-dependent. Surprisingly, in p53-null H1299 cells, there was no up-regulation of NDRG-1 after incubation with chelators (Fig. 4) . This was unexpected, because these cells are HIF-1␣(ϩ/ϩ) and should respond as in the studies shown in Fig. 2 . Chelator-mediated increase in gene expression is reversible by reincubation with the soluble iron source FAC. MCF-7 cells were incubated for 18 h at 37°C with CON alone or CON containing DFO (250 M) or 311 (25 M) (primary incubation). This medium was then removed, and the cells were reincubated for 22 h at 37°C with either CON alone or CON containing either FAC (100 g/ml), DFO (250 M), or 311 (25 M) (secondary incubation). The mRNA expression of the seven genes examined in Fig. 1 was then examined in comparison with the known iron-regulated genes NDRG-1 and TfR1 (positive controls). Densitometry was performed and gene expression was then calculated relative to the ␤-actin control. Results are mean Ϯ S.D. of three experiments. ‫,ء‬ p Ͻ 0.05; ‫,ءء‬ p Ͻ 0.01; ‫,ءءء‬ p Ͻ 0.001. 450 Fig. 3 . However, this result may suggest that both p53 and HIF-1␣ are necessary for chelator-mediated up-regulation of NDRG-1 in these cells. In fact, HIF-1␣ is known to be able to stabilize p53 (An et al., 1998) , which may explain these 
observations. For all other genes, their expression was increased after incubation with chelators in the presence or absence of p53, indicating p53-dependent and -independent mechanisms.
Iron-Regulated Gene Expression in Neoplastic Cells Compared with Normal Cells
Considering the significant (p Ͻ 0.05) differential regulation of 16 genes in Table 2 by both DFO and 311 in MCF-7 cells, studies assessed whether this effect was also observed in normal cells incubated with the same concentration of chelators (Fig. 5, A and B) . In these experiments, we compared neoplastic MCF-7 cells with normal MRC-5 fibroblasts. This was done because we showed that proliferation of MCF-7 cells is highly sensitive to chelators relative to normal MRC-5 cells (Yuan et al., 2004) and that these ligands lead to iron mobilization from both cell types (Liang and Richardson, 2003; Yuan et al., 2004) . Thus, an analysis of the expression of these 16 genes in both cell types may lead to improved understanding of the reason for the known antiproliferative efficacy of chelators against neoplastic relative to normal cells (Buss et al., 2003) .
Five of the sixteen genes in Table 2 (namely APP, CITED2, EGR1, GDF15, and PNRC1) displayed differential regulation between MCF-7 and MRC-5 cells (Fig. 5A) , whereas the remaining 11 genes showed similar up-regulation in both cell types (Fig. 5B) . Hence, the differential gene expression observed between these cells could be important for understanding the sensitivity of cancer cells to chelators (Buss et al., 2003) . Considering these results, it was essential to determine whether these differences in expression were evident in multiple tumor and normal cell types (Figs. 6 and 7) .
To determine this, we examined the mRNA and protein expression of the five genes above that were differentially regulated between MCF-7 and MRC-5 cells in three other cancer cell lines (DMS53 lung cancer cells, SK-Mel-28 melanoma cells, SK-N-MC neuroepithelioma cells) and two other normal cell types (HUVECs and fibroblasts; Figs. 6 and 7) .
At the mRNA level, CITED2, EGR1, GDF15, and PNRC1 were significantly up-regulated by chelators to a significantly (p Ͻ 0.05) greater extent in neoplastic cells than in normal cells (Fig. 6 ). Differential regulation of these genes was even more marked when assessing protein levels, CITED2, EGR1, and GDF15 being significantly (p Ͻ 0.005) up-regulated by both chelators in neoplastic cells with either no effect or down-regulation occurring in normal cells (Fig. 7) . The antibody available for PNRC1 did not lead to reproducible results; thus, these data were not included. For all cell types, the positive control TfR1 was significantly up-regulated by chelators, demonstrating that iron depletion had occurred (Fig. 7) .
It of interest that for the five genes analyzed in Figs. 6 and 7, mRNA levels were not always predictive of protein levels. For example, this is true of CITED2 and GDF15 in at least two of the three normal cell lines. Indeed, for the latter two molecules, protein levels were the opposite of what one would anticipate based upon RNA analyses. This difference can be rationalized by post-transcriptional and post-translational processing.
Discussion
Despite the fact that iron-deficiency anemia remains a severe global problem, little is known concerning the role of iron in regulating mammalian gene expression. Furthermore, the use of chelators for the treatment of iron overload disease and their use in the treatment of other conditions such as cancer (Buss et al., 2003) , necessitates knowledge of how alterations in cellular iron levels affect gene expression. In fact, several chelators are being developed for cancer treatment (Buss et al., 2003) ; one of these, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine), has entered a variety of phase II clinical trials (Buss et al., 2003; Yu et al., 2009 ). Some of these investigations have shown that 3-aminopyridine-2-carboxaldehyde thiosemicarbazone is not highly effective and justifies the development of more effective ligands (e.g., Dp44mT) (Yu et al., 2009) .
In this study, we used whole-genome gene array to assess alterations in gene expression after incubation with two well The presence (ϩ) or absence (Ϫ) of p53 and/or HIF-1␣, either in the literature (as regulating molecules) or in the sequence search using Genomatix [as p53 binding sequence or hypoxia response element (HRE)], is indicated.
Gene Symbol Function
Literature Genomatix p53 HIF-1␣ References p53 HRE APP Cell proliferation and oxidative stress ϩ ϩ Ozaki et al., 2006; Wang et al., 2006; Zhang et al., 2007 . ϩ ϩ BHLHB2
Cell growth and differentiation Ϫ ϩ Ivanova et al., 2001; Miyazaki et al., 2002; Chakrabarti et al., 2004; Currie et al., 2004; Yamada and Miyamoto, 2005 Ϫ ϩ (Darnell and Richardson, 1999; Richardson and Bernhardt, 1999) . For the first time, we identify a wide range of genes that have not been described previously as being regulated by intracellular iron levels. In fact, there were 16 genes significantly regulated by both 311 and DFO (Table 2) and a further 50 genes significantly regulated by one or the other chelator (Tables 3 and 4) . These genes represent molecules with various functions, those of the nucleic acid-binding class being the most commonly up-or down-regulated (Table 5) . Although DFO and 311 are well characterized iron(III) chelators, their different permeability characteristics and iron chelation efficacy (Darnell and Richardson, 1999; Richardson and Bernhardt, 1999) lead to some variation in response (Table 5) .
BNIP3
Of the sixteen genes commonly and significantly regulated by both chelators (Table 2) , seven were further characterized for reasons of practicality. All seven were confirmed to be reversibly regulated after iron depletion by the addition of FAC (Fig. 2) , which is well known to replenish iron pools (Le and Richardson, 2004) . Hence, the effects of the chelators on altering the expression of these genes cannot be interpreted to be due to another effect separate from iron binding.
By and large, the regulation of gene expression by iron in mammalian cells has been described to be via IRE-IRP and, to a lesser extent, HIF-1␣ mechanisms (Semenza, 1999; Sanchez et al., 2007) . However, there is evidence that the transcription factor p53 is up-regulated by iron depletion (An et al., 1998; Liang and Richardson, 2003) , and this could occur via HIF-1␣, which stabilizes p53 (An et al., 1998) . Furthermore, it has been shown that p53 can post-transcrip- 
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tionally regulate iron homeostasis (Zhang et al., 2008) . Hence, it was important to examine whether any of the alterations in gene expression observed could be due to these mechanisms. None of the up-regulated genes in Table 2 contained canonical IREs in the 3Ј UTR; thus, IRE-IRP binding could probably not explain the up-regulation observed. However, both chelators led to significant up-regulation of three (BNIP3, EGR1, and ERO1L) of the seven genes characterized in Fig. 1, B and C, by a HIF-1␣-dependent mechanism (Fig.  3B) . It is noteworthy that these genes have been shown to be regulated by HIF-1␣ under other experimental conditions (Bruick, 2000; Gess et al., 2003; Tai et al., 2009) .
The products of BNIP3, EGR1, and ERO1L are involved in apoptosis (Bruick, 2000) , the increased expression of multiple tumor suppressors (TGF␤1, PTEN, p53, and fibronectin) (Baron et al., 2006) and redox homeostasis (Sevier and Kaiser, 2008) , respectively. Thus, their increased expression could participate in the antiproliferative activity of iron chelators. Furthermore, EGR1 is necessary for trans-activation of the HIF-1␣ promoter (Sperandio et al., 2009) , potentially resulting in a positive feed-forward loop in response to iron depletion, leading to increased HIF-1␣, which then increases EGR1.
In additional studies, we examined the role of p53 in the response to iron depletion using H1299 cells (p53-null) transfected with wild-type p53. Chelator-mediated up-regulation by a p53-dependent mechanism was identified for GDF15, NDRG-1, and PPM1D. These genes were not up-regulated by the ligands in the absence of p53, indicating the specificity of the response. All of these genes contain a consensus p53-binding element within the promoter and have been shown previously to be regulated via p53 by a range of other stimuli (Table 6) . Considering their functions, GDF15, NDRG-1, and PPM1D play roles in apoptosis (Jutooru et al., 2009 ), growth and metastasis suppression (Le and Richardson, 2004) , and the regulation of p53, respectively (Lu et al., 2007) . Hence, their effects on inhibiting tumor growth are notable when considering the antiproliferative activity of chelators.
Part of the rationale of this investigation was to decipher alterations in gene expression by chelators that could help explain the sensitivity of neoplastic cells to these agents relative to normal cells (Buss et al., 2003; Yu et al., 2009 ). In fact, CITED2, EGR1, GDF15, and PNRC1, were significantly up-regulated by DFO and 311 in four different neoplastic cell lines relative to three normal cell types. Each of these molecules has antiproliferative effects, and their collective activ- 
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ity could be significant in terms of the antitumor efficacy of chelators (Buss et al., 2003) . For instance, the transcriptional modulator CITED2 arrests cell growth and is also related to reduced expression of matrix metalloproteinase-13, which is linked to metastasis (Bai and Merchant, 2007) . As described above, EGR1 and GDF15 have antitumor activity, and the chelator-mediated increase in expression is dependent on HIF-1␣ and p53, respectively. In fact, EGR1 is associated with susceptibility to apoptosis (Zagurovskaya et al., 2009) and expression of p21 (Choi et al., 2008) , which inhibits proliferation. GDF15 is also known as nonsteroidal antiinflammatory drug-activated gene-1 or macrophage inhibitory cytokine-1/prostate-derived factor and is a putative tumor suppressor (Yoshioka et al., 2008 ) the expression of which is increased by antitumor agents. As such, this molecule has been suggested to be a target for cancer treatment (Martinez et al., 2006) . Furthermore, PNRC1 interacts with the Grb2-adaptor protein involved in growth factor/Ras-mediated pathways, and PNRC1 overexpression can inhibit cancer cell proliferation (Zhou et al., 2004) . 
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Apart from the up-regulation of the genes described above in neoplastic cells, it was also of interest that APP was generally expressed to a higher extent at the mRNA and protein levels in normal relative to tumor cells after incubation with chelators. Hence, the lower expression of APP after Fe chelation in tumor cells may lead to inhibition of proliferation, in that this molecule is known to promote cancer growth (Takayama et al., 2009) .
A subset of the 16 genes identified in Table 2 were similarly regulated by iron chelation in both normal and neoplastic cell types (Fig. 5B) . Considering this, after iron chelation therapy is given to patients for iron-overload disease, it can be expected that some of the alterations in gene expression reported herein could potentially be observed. Hence, the work described here is also important for understanding the response of both normal and neoplastic cells to iron chelation.
It is of interest that iron chelators affect a wide variety of targets, and the differential expression and function of the genes identified here must be considered in conjunction with the effects of the ligands on a variety of other molecules, Fig. 7 . Comparative data analysis of ironregulated proteins showing differential expression between neoplastic cell lines (DMS-53, MCF-7, SK-Mel-28, and SK-N-MC) and normal cells (HUVECs, MRC-5, and fibroblasts) after incubation with either DFO (250 M) or 311 (25 M) for 24 h at 37°C compared with CON. The protein was extracted, and Western analysis and densitometry were then performed. Gene expression (log 2 ) was calculated relative to the ␤-actin loading control for each cell type and is placed at the bottom of the figure for clarity. The photographs of Western blots are representative of at least three to six separate experiments performed, and the densitometry results are expressed as mean Ϯ S.D. of three to six experiments). ‫,ء‬ p Ͻ 0.05; ‫,ءء‬ p Ͻ 0.01; ‫,ءءء‬ p Ͻ 0.001 compared with the relevant CON for each cell type.
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including cyclin D1, the cyclin-dependent kinase inhibitor p21 CIP1/WAF1 , GADD45 (Darnell and Richardson, 1999; Gao and Richardson, 2001) , ribonucleotide reductase, NDRG-1 (Le and , etc. The importance of iron chelators having multiple molecular targets could be significant for understanding why these agents inhibit tumor growth. In fact, the effect of iron depletion on activation of HIF-1␣ has been linked to the stimulation of tumor angiogenesis and resistance to chemotherapy. For example, Elstner et al., (2007) showed that DFO-induced iron depletion significantly enhanced glioblastoma cell invasion in vitro. However, apart from its tumor-stimulating activity, HIF-1␣ can also potentially have antitumor effects by up-regulating the pro-apoptotic molecule BNIP3 (Bruick, 2000) and the potent tumor suppressor p53 (An et al., 1998) . The fact that potent iron chelators markedly prevent tumor growth in vivo (Buss et al., 2003; Yu et al., 2009) indicates that their antitumor effects rather than pro-tumor activity predominates. This may be true not only via the paradoxical activity of HIF-1␣ but also through the many other molecular targets of iron chelators (ribonucleotide reductase, etc.).
In conclusion, for the first time, we have identified a wide range of genes significantly regulated by chelation of cellular iron pools. In addition to iron-mediated regulation of expression of BNIP3, EGR1, and ERO1L via a HIF-1␣-dependent mechanism, we also showed that p53 played a role in the iron-mediated regulation of GDF15, NDRG-1, and PPM1D. Sixteen genes were identified to be commonly regulated by DFO and 311. Of these, five were differentially regulated in tumor cells relative to normal cells. These molecules have antitumor functions, and their upregulation could be significant in explaining the sensitivity of cancer cells to chelators. Moreover, these studies achieve a more comprehensive understanding of the diverse cellular responses to iron depletion.
